Evasion of host immunity by virulent salmonella: Implications for vaccine design

Current Medicinal Chemistry

Volumn 18, Issue 36, 2011, Pages 5666-5675

  Riquelme, S A ^a   Wozniak, A ^a   Kalergis, A M ^a,b   Bueno, S M ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Dendritic cell; Live attenuated bacteria; Phagosome maturation; Salmonella Pathogenicity Island; Salmonella Typhimurium; T cell; Type Three secretion system; Vaccination

Indexed keywords

BACTERIAL ANTIGEN; EAMZ 250; EASZ 240; EPITOPE; FC RECEPTOR; RECOMBINANT ANTIGEN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIGEN PRESENTATION; ARTICLE; BACTERIAL CELL; BACTERIAL VIRULENCE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INVASION; CELL MATURATION; CYTOPLASM; DENDRITIC CELL; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; INFLAMMATION; LYMPH NODE; MACROPHAGE; NONHUMAN; PHAGOCYTE; PHAGOSOME; SALMONELLA; SCORING SYSTEM; SURVIVAL; T LYMPHOCYTE; VACCINATION; VECTOR CONTROL;

EID: 84055189565     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711798347333     Document Type: Article

References (151)

1. Steinman, R.M.; Cohn, Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med, 1973, 137 (5), 1142-1162.
2. Dominguez, P.M.; Ardavin, C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev, 2010, 234 (1), 90-104.
3. Banchereau, J.; Briere, F.; Caux, C.; Davoust, J.; Lebecque, S.; Liu, Y.J.; Pulendran, B.; Palucka, K. Immunobiology of dendritic cells. Annu Rev Immunol, 2000, 18:767-811. (Pubitemid 30365397)
4. Herrada, A.A.; Contreras, F.J.; Marini, N.P.; Amador, C.A.; Gonzalez, P.A.; Cortes, C.M.; Riedel, C.A.; Carvajal, C.A.; Figueroa, F.; Michea, L.F.; Fardella, C.E.; Kalergis, A.M. Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol, 2010, 184 (1), 191-202.
5. Pacheco, R.; Riquelme, E.; Kalergis, A.M. Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands. Cent Nerv Syst Agents Med Chem, 2010, 10 (1), 65-83.
6. Carreno, L.J.; Riquelme, E.M.; Gonzalez, P.A.; Espagnolle, N.; Riedel, C.A.; Valitutti, S.; Kalergis, A.M. T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC. Proc Natl Acad Sci U S A, 2010, 107 (1), 210-215.
7. Gonzalez, P.A.; Carreno, L.J.; Figueroa, C.A.; Kalergis, A.M. Modulation of immunological synapse by membrane-bound and soluble ligands. Cytokine Growth Factor Rev, 2007, 18 (1-2), 19-31. (Pubitemid 46401428)
8. Bueno, S.M.; Gonzalez, P.A.; Cautivo, K.M.; Mora, J.E.; Leiva, E.D.; Tobar, H.E.; Fennelly, G.J.; Eugenin, E.A.; Jacobs, W.R., Jr.; Riedel, C.A.; Kalergis, A.M. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci U S A, 2008, 105 (52), 20822-20827.
9. Erb, P.; Kennedy, M.; Wassmer, P.; Huegli, G. Antigen-presenting cells and T cell activation. Agents Actions, 1986, 19 (5-6), 266-268. (Pubitemid 17205453)
10. Wang, R.; Murphy, K.M.; Loh, D.Y.; Weaver, C.; Russell, J.H. Differential activation of antigen-stimulated suicide and cytokine production pathways in CD4+ T cells is regulated by the antigen-presenting cell. J Immunol, 1993, 150 (9), 3832-3842. (Pubitemid 23129765)
11. Bousso, P. T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat Rev Immunol, 2008, 8 (9), 675-684.
12. Riquelme, E.; Carreno, L.J.; Gonzalez, P.A.; Kalergis, A.M. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity. Eur J Immunol, 2009, 39 (8), 2259-2269.
13. Carreno, L.J.; Bueno, S.M.; Bull, P.; Nathenson, S.G.; Kalergis, A.M. The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge. Immunology, 2007, 121 (2), 227-237. (Pubitemid 46663091)
14. Carreno, L.J.; Gonzalez, P.A.; Kalergis, A.M. Modulation of T cell function by TCR/pMHC binding kinetics. Immunobiology, 2006, 211 (1-2), 47-64. (Pubitemid 43150108)
15. Gonzalez, P.A.; Carreno, L.J.; Coombs, D.; Mora, J.E.; Palmieri, E.; Goldstein, B.; Nathenson, S.G.; Kalergis, A.M. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci U S A, 2005, 102 (13), 4824-4829. (Pubitemid 40471538)
16. Kalergis, A.M. Modulation of T cell immunity by TCR/pMHC dwell time and activating/inhibitory receptor pairs on the antigen-presenting cell. Curr Pharm Des, 2003, 9 (3), 233-244. (Pubitemid 36131717)
17. Carreno, L.J.; Gonzalez, P.A.; Bueno, S.M.; Riedel, C.A.; Kalergis, A.M. Modulation of the dendritic cell-T-cell synapse to promote pathogen immunity and prevent autoimmunity. Immunotherapy, 2011, 3 (4 Suppl), 6-11.
18. Llanos, C.; Carreno, L.J.; Kalergis, A.M. Contribution of dendritic cell/T cell interactions to triggering and maintaining autoimmunity. Biol Res, 2011, 44 (1), 53-61.
19. Iruretagoyena, M.I.; Wiesendanger, M.; Kalergis, A.M. The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis. Curr Pharm Des, 2006, 12 (2), 131-147.
20. Bueno, S.M.; Tobar, J.A.; Iruretagoyena, M.I.; Kalergis, A.M. Molecular interactions between dendritic cells and Salmonella: escape from adaptive immunity and implications on pathogenesis. Crit Rev Immunol, 2005, 25 (5), 389-403. (Pubitemid 43068933)
21. Bedoui, S.; Kupz, A.; Wijburg, O.L.; Walduck, A.K.; Rescigno, M.; Strugnell, R.A. Different bacterial pathogens, different strategies, yet the aim is the same: evasion of intestinal dendritic cell recognition. J Immunol, 2010, 184 (5), 2237-2242.
22. Gonzalez, P.A.; Bueno, S.M.; Riedel, C.A.; Kalergis, A.M. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. Curr Med Chem, 2009, 16 (34), 4609-4625.
23. Bueno, S.M.; Gonzalez, P.A.; Pacheco, R.; Leiva, E.D.; Cautivo, K.M.; Tobar, H.E.; Mora, J.E.; Prado, C.E.; Zuniga, J.P.; Jimenez, J.; Riedel, C.A.; Kalergis, A.M. Host immunity during RSV pathogenesis. Int Immunopharmacol, 2008, 8 (10), 1320-1329.
24. Bueno, S.M.; Wozniak, A.; Leiva, E.D.; Riquelme, S.A.; Carreno, L.J.; Hardt, W.D.; Riedel, C.A.; Kalergis, A.M. Salmonella pathogenicity island 1 differentially modulates bacterial entry to dendritic and non-phagocytic cells. Immunology, 2010.
25. Cheminay, C.; Mohlenbrink, A.; Hensel, M. Intracellular Salmonella inhibit antigen presentation by dendritic cells. J Immunol, 2005, 174 (5), 2892-2899. (Pubitemid 40279707)
26. Chattopadhyay, A.; Robinson, N.; Sandhu, J.K.; Finlay, B.B.; Sad, S.; Krishnan, L. Salmonella Typhimurium induced placental inflammation and not bacterial burden correlates with pathology and fatal maternal disease. Infect Immun, 2010.
27. Coburn, B.; Grassl, G.A.; Finlay, B.B. Salmonella, the host and disease: a brief review. Immunol Cell Biol, 2007, 85 (2), 112-118. (Pubitemid 46398718)
28. Bueno, S.M.; Riedel, C.A.; Carreno, L.J.; Kalergis, A.M. Virulence mechanisms displayed by Salmonella to impair dendritic cell function. Curr Med Chem, 2010, 17 (12), 1156-1166.
29. Bueno, S.M.; Gonzalez, P.A.; Carreno, L.J.; Tobar, J.A.; Mora, G.C.; Pereda, C.J.; Salazar-Onfray, F.; Kalergis, A.M. The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific. Immunology, 2008, 124 (4), 522-533. (Pubitemid 351962548)
30. Pang, T.; Levine, M.M.; Ivanoff, B.; Wain, J.; Finlay, B.B. Typhoid fever-important issues still remain. Trends Microbiol, 1998, 6 (4), 131-133.
31. House, D.; Bishop, A.; Parry, C.; Dougan, G.; Wain, J. Typhoid fever: pathogenesis and disease. Curr Opin Infect Dis, 2001, 14 (5), 573-578. (Pubitemid 32929620)
32. Tobar, J.A.; Carreno, L.J.; Bueno, S.M.; Gonzalez, P.A.; Mora, J.E.; Quezada, S.A.; Kalergis, A.M. Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. Infect Immun, 2006, 74 (11), 6438-6448. (Pubitemid 44657426)
33. Albaghdadi, H.; Robinson, N.; Finlay, B.; Krishnan, L.; Sad, S. Selectively reduced intracellular proliferation of Salmonella enterica serovar typhimurium within APCs limits antigen presentation and development of a rapid CD8 T cell response. J Immunol, 2009, 183 (6), 3778-3787.
34. Lawley, T.D.; Chan, K.; Thompson, L.J.; Kim, C.C.; Govoni, G.R.; Monack, D.M. Genome-wide screen for Salmonella genes required for long-term systemic infection of the mouse. PLoS Pathog, 2006, 2 (2), e11.
35. Cheminay, C.; Schoen, M.; Hensel, M.; Wandersee-Steinhauser, A.; Ritter, U.; Korner, H.; Rollinghoff, M.; Hein, J. Migration of Salmonella typhimurium -harboring bone marrow-derived dendritic cells towards the chemokines CCL19 and CCL21. Microb Pathog, 2002, 32 (5), 207-218. (Pubitemid 34729215)
36. Tobar, J.A.; Gonzalez, P.A.; Kalergis, A.M. Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells. J Immunol, 2004, 173 (6), 4058-4065. (Pubitemid 39280770)
37. Bueno, S.M.; Gonzalez, P.A.; Schwebach, J.R.; Kalergis, A.M. T cell immunity evasion by virulent Salmonella enterica. Immunol Lett, 2007, 111 (1), 14-20. (Pubitemid 47017478)
38. Savidge, T.C.; Smith, M.W.; James, P.S.; Aldred, P. Salmonella-induced Mcell formation in germ-free mouse Peyer's patch tissue. Am J Pathol, 1991, 139 (1), 177-184.
39. Monack, D.M.; Hersh, D.; Ghori, N.; Bouley, D.; Zychlinsky, A.; Falkow, S. Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model. J Exp Med, 2000, 192 (2), 249-258. (Pubitemid 30470307)
40. Hapfelmeier, S.; Stecher, B.; Barthel, M.; Kremer, M.; Muller, A.J.; Heikenwalder, M.; Stallmach, T.; Hensel, M.; Pfeffer, K.; Akira, S.; Hardt, W.D. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol, 2005, 174 (3), 1675-1685.
41. Jepson, M.A.; Clark, M.A. The role of M cells in Salmonella infection. Microbes Infect, 2001, 3 (14-15), 1183-1190. (Pubitemid 34033753)
42. Hashim, S.; Mukherjee, K.; Raje, M.; Basu, S.K.; Mukhopadhyay, A. Live Salmonella modulate expression of Rab proteins to persist in a specialized compartment and escape transport to lysosomes. J Biol Chem, 2000, 275 (21), 16281-16288. (Pubitemid 30366942)
43. Beuzon, C.R.; Meresse, S.; Unsworth, K.E.; Ruiz-Albert, J.; Garvis, S.; Waterman, S.R.; Ryder, T.A.; Boucrot, E.; Holden, D.W. Salmonella maintains the integrity of its intracellular vacuole through the action of SifA. Embo J, 2000, 19 (13), 3235-3249. (Pubitemid 30428202)
44. Smith, A.C.; Heo, W.D.; Braun, V.; Jiang, X.; Macrae, C.; Casanova, J.E.; Scidmore, M.A.; Grinstein, S.; Meyer, T.; Brumell, J.H. A network of Rab GTPases controls phagosome maturation and is modulated by Salmonella enterica serovar Typhimurium. J Cell Biol, 2007, 176 (3), 263-268. (Pubitemid 46184877)
45. Stender, S.; Friebel, A.; Linder, S.; Rohde, M.; Mirold, S.; Hardt, W.D. Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol Microbiol, 2000, 36 (6), 1206-1221. (Pubitemid 30449959)
46. Mirold, S.; Ehrbar, K.; Weissmuller, A.; Prager, R.; Tschape, H.; Russmann, H.; Hardt, W.D. Salmonella host cell invasion emerged by acquisition of a mosaic of separate genetic elements, including Salmonella pathogenicity island 1 (SPI1), SPI5, and sopE2. J Bacteriol, 2001, 183 (7), 2348-2358. (Pubitemid 32240407)
47. Raffatellu, M.; Wilson, R.P.; Chessa, D.; Andrews-Polymenis, H.; Tran, Q.T.; Lawhon, S.; Khare, S.; Adams, L.G.; Baumler, A.J. SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype typhimurium invasion of epithelial cells. Infect Immun, 2005, 73 (1), 146-154. (Pubitemid 40041104)
48. Zhou, D.; Galan, J. Salmonella entry into host cells: the work in concert of type III secreted effector proteins. Microbes Infect, 2001, 3 (14-15), 1293-1298. (Pubitemid 34033764)
49. Zhou, D. Collective efforts to modulate the host actin cytoskeleton by Salmonella type III-secreted effector proteins. Trends Microbiol, 2001, 9 (12), 567-569; discussion 569-570. (Pubitemid 33135403)
50. Gerlach, R.G.; Claudio, N.; Rohde, M.; Jackel, D.; Wagner, C.; Hensel, M. Cooperation of Salmonella pathogenicity islands 1 and 4 is required to breach epithelial barriers. Cell Microbiol, 2008, 10 (11), 2364-2376.
51. Hansen-Wester, I.; Hensel, M. Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect, 2001, 3 (7), 549-559. (Pubitemid 32539465)
52. Ehrbar, K.; Hardt, W.D. Bacteriophage-encoded type III effectors in Salmonella enterica subspecies 1 serovar Typhimurium. Infect Genet Evol, 2005, 5 (1), 1-9. (Pubitemid 39619012)
53. Cornelis, G.R. Type III secretion: a bacterial device for close combat with cells of their eukaryotic host. Philos Trans R Soc Lond B Biol Sci, 2000, 355 (1397), 681-693. (Pubitemid 30354753)
54. Cornelis, G.R.; Van Gijsegem, F. Assembly and function of type III secretory systems. Annu Rev Microbiol, 2000, 54 :735-774.
55. Troisfontaines, P.; Cornelis, G.R. Type III secretion: more systems than you think. Physiology (Bethesda), 2005, 20 :326-339. (Pubitemid 41457398)
56. Paesold, G.; Guiney, D.G.; Eckmann, L.; Kagnoff, M.F. Genes in the Salmonella pathogenicity island 2 and the Salmonella virulence plasmid are essential for Salmonella-induced apoptosis in intestinal epithelial cells. Cell Microbiol, 2002, 4 (11), 771-781. (Pubitemid 35378716)
57. Giacomodonato, M.N.; Sarnacki, S.H.; Llana, M.N.; Cerquetti, M.C. SopB effector protein of Salmonella Typhimurium is translocated in mesenteric lymph nodes during murine salmonellosis. FEMS Microbiol Lett, 2011, 317 (1), 100-106.
58. Silva-Herzog, E.; Detweiler, C.S. Salmonella enterica replication in hemophagocytic macrophages requires two type three secretion systems. Infect Immun, 2010, 78 (8), 3369-3377.
59. Herrada, A.A.; Contreras, F.J.; Tobar, J.A.; Pacheco, R.; Kalergis, A.M. Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells. Proc Natl Acad Sci U S A, 2007, 104 (33), 13402-13407. (Pubitemid 47293957)
60. Mukherjee, K.; Siddiqi, S.A.; Hashim, S.; Raje, M.; Basu, S.K.; Mukhopadhyay, A. Live Salmonella recruits N-ethylmaleimide-sensitive fusion protein on phagosomal membrane and promotes fusion with early endosome. J Cell Biol, 2000, 148 (4), 741-753.
61. Buchmeier, N.A.; Heffron, F. Inhibition of macrophage phagosomelysosome fusion by Salmonella typhimurium. Infect Immun, 1991, 59 (7), 2232-2238.
62. Frost, A.J.; Bland, A.P.; Wallis, T.S. The early dynamic response of the calf ileal epithelium to Salmonella typhimurium. Vet Pathol, 1997, 34 (5), 369-386. (Pubitemid 127470270)
63. Reis, B.P.; Zhang, S.; Tsolis, R.M.; Baumler, A.J.; Adams, L.G.; Santos, R.L. The attenuated sopB mutant of Salmonella enterica serovar Typhimurium has the same tissue distribution and host chemokine response as the wild type in bovine Peyer's patches. Vet Microbiol, 2003, 97 (3-4), 269-277. (Pubitemid 37494831)
64. Santos, R.L.; Schoffelmeer, J.A.; Tsolis, R.M.; Gutierrez-Pabello, J.A.; Baumler, A.J.; Adams, L.G. Salmonella serotype Typhimurium infection of bovine Peyer's patches down-regulates plasma membrane calciumtransporting ATPase expression. J Infect Dis, 2002, 186 (3), 372-378. (Pubitemid 34816320)
65. Santos, R.L.; Zhang, S.; Tsolis, R.M.; Baumler, A.J.; Adams, L.G. Morphologic and molecular characterization of Salmonella typhimurium infection in neonatal calves. Vet Pathol, 2002, 39 (2), 200-215.
66. Iwasaki, A.; Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat Immunol, 2004, 5 (10), 987-995. (Pubitemid 41057715)
67. Hayashi, F.; Smith, K.D.; Ozinsky, A.; Hawn, T.R.; Yi, E.C.; Goodlett, D.R.; Eng, J.K.; Akira, S.; Underhill, D.M.; Aderem, A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature, 2001, 410 (6832), 1099-1103. (Pubitemid 32391041)
68. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, C.A., Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 1997, 388 (6640), 394-397. (Pubitemid 27334820)
69. Poltorak, A.; He, X.; Smirnova, I.; Liu, M.Y.; Van Huffel, C.; Du, X.; Birdwell, D.; Alejos, E.; Silva, M.; Galanos, C.; Freudenberg, M.; Ricciardi-Castagnoli, P.; Layton, B.; Beutler, B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 1998, 282 (5396), 2085-2088. (Pubitemid 29001265)
70. Wright, S.D.; Ramos, R.A.; Tobias, P.S.; Ulevitch, R.J.; Mathison, J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science, 1990, 249 (4975), 1431-1433.
71. Nau, G.J.; Schlesinger, A.; Richmond, J.F.; Young, R.A. Cumulative Tolllike receptor activation in human macrophages treated with whole bacteria. J Immunol, 2003, 170 (10), 5203-5209. (Pubitemid 36554753)
72. Zeng, H.; Carlson, A.Q.; Guo, Y.; Yu, Y.; Collier-Hyams, L.S.; Madara, J.L.; Gewirtz, A.T.; Neish, A.S. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol, 2003, 171 (7), 3668-3674. (Pubitemid 37254570)
73. Zhang, Y.; Higashide, W.M.; McCormick, B.A.; Chen, J.; Zhou, D. The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase. Mol Microbiol, 2006, 62 (3), 786-793. (Pubitemid 44571602)
74. Uematsu, S.; Jang, M.H.; Chevrier, N.; Guo, Z.; Kumagai, Y.; Yamamoto, M.; Kato, H.; Sougawa, N.; Matsui, H.; Kuwata, H.; Hemmi, H.; Coban, C.; Kawai, T.; Ishii, K.J.; Takeuchi, O.; Miyasaka, M.; Takeda, K.; Akira, S. Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat Immunol, 2006, 7 (8), 868-874. (Pubitemid 44084094)
75. Uematsu, S.; Akira, S. Immune responses of TLR5(+) lamina propria dendritic cells in enterobacterial infection. J Gastroenterol, 2009, 44 (8), 803-811.
76. Hersh, D.; Monack, D.M.; Smith, M.R.; Ghori, N.; Falkow, S.; Zychlinsky, A. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci U S A, 1999, 96 (5), 2396-2401. (Pubitemid 29117926)
77. van der Velden, A.W.; Velasquez, M.; Starnbach, M.N. Salmonella rapidly kill dendritic cells via a caspase-1-dependent mechanism. J Immunol, 2003, 171 (12), 6742-6749. (Pubitemid 37532107)
78. Sun, Y.H.; Rolan, H.G.; Tsolis, R.M. Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium. J Biol Chem, 2007, 282 (47), 33897-33901. (Pubitemid 350159422)
79. Fink, S.L.; Cookson, B.T. Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol, 2007, 9 (11), 2562-2570. (Pubitemid 47500510)
80. Brennan, M.A.; Cookson, B.T. Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol, 2000, 38 (1), 31-40.
81. Cookson, B.T.; Brennan, M.A. Pro-inflammatory programmed cell death. Trends Microbiol, 2001, 9 (3), 113-114.
82. Bueno, S.M.; Gonzalez, P.A.; Riedel, C.A.; Carreno, L.J.; Vasquez, A.E.; Kalergis, A.M. Local cytokine response upon respiratory syncytial virus infection. Immunol Lett, 2011, 136 (2), 122-129.
83. Kalergis, A.M.; Iruretagoyena, M.I.; Barrientos, M.J.; Gonzalez, P.A.; Herrada, A.A.; Leiva, E.D.; Gutierrez, M.A.; Riedel, C.A.; Bueno, S.M.; Jacobelli, S.H. Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology, 2009, 128 (1 Suppl), e306-314.
84. Fantuzzi, G.; Dinarello, C.A. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol, 1999, 19 (1), 1-11. (Pubitemid 29113328)
85. Dreher, D.; Kok, M.; Obregon, C.; Kiama, S.G.; Gehr, P.; Nicod, L.P. Salmonella virulence factor SipB induces activation and release of IL-18 in human dendritic cells. J Leukoc Biol, 2002, 72 (4), 743-751. (Pubitemid 36277846)
86. Revolledo, L.; Ferreira, C.S.; Ferreira, A.J. Prevention of Salmonella Typhimurium colonization and organ invasion by combination treatment in broiler chicks. Poult Sci, 2009, 88 (4), 734-743.
87. Giacomodonato, M.N.; Uzzau, S.; Bacciu, D.; Caccuri, R.; Sarnacki, S.H.; Rubino, S.; Cerquetti, M.C. SipA, SopA, SopB, SopD and SopE2 effector proteins of Salmonella enterica serovar Typhimurium are synthesized at late stages of infection in mice. Microbiology, 2007, 153 (Pt 4), 1221-1228. (Pubitemid 46605820)
88. Voedisch, S.; Koenecke, C.; David, S.; Herbrand, H.; Forster, R.; Rhen, M.; Pabst, O. Mesenteric lymph nodes confine dendritic cell-mediated dissemination of Salmonella enterica serovar Typhimurium and limit systemic disease in mice. Infect Immun, 2009, 77 (8), 3170-3180.
89. Bogunovic, M.; Ginhoux, F.; Helft, J.; Shang, L.; Hashimoto, D.; Greter, M.; Liu, K.; Jakubzick, C.; Ingersoll, M.A.; Leboeuf, M.; Stanley, E.R.; Nussenzweig, M.; Lira, S.A.; Randolph, G.J.; Merad, M. Origin of the lamina propria dendritic cell network. Immunity, 2009, 31 (3), 513-525.
90. Knodler, L.A.; Finlay, B.B.; Steele-Mortimer, O. The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt. J Biol Chem, 2005, 280 (10), 9058-9064. (Pubitemid 40409599)
91. McGhie, E.J.; Hayward, R.D.; Koronakis, V. Control of actin turnover by a salmonella invasion protein. Mol Cell, 2004, 13 (4), 497-510. (Pubitemid 38299378)
92. Alaniz, R.C.; Cummings, L.A.; Bergman, M.A.; Rassoulian-Barrett, S.L.; Cookson, B.T. Salmonella typhimurium coordinately regulates FliC location and reduces dendritic cell activation and antigen presentation to CD4+ T cells. J Immunol, 2006, 177 (6), 3983-3993. (Pubitemid 44359931)
93. Halici, S.; Zenk, S.F.; Jantsch, J.; Hensel, M. Functional analysis of the Salmonella pathogenicity island 2-mediated inhibition of antigen presentation in dendritic cells. Infect Immun, 2008, 76 (11), 4924-4933.
94. Garcia-Del Portillo, F.; Jungnitz, H.; Rohde, M.; Guzman, C.A. Interaction of Salmonella enterica serotype Typhimurium with dendritic cells is defined by targeting to compartments lacking lysosomal membrane glycoproteins. Infect Immun, 2000, 68 (5), 2985-2991. (Pubitemid 30253882)
95. Vieira, O.V.; Botelho, R.J.; Grinstein, S. Phagosome maturation: aging gracefully. Biochem J, 2002, 366 (Pt 3), 689-704.
96. Vieira, O.V.; Bucci, C.; Harrison, R.E.; Trimble, W.S.; Lanzetti, L.; Gruenberg, J.; Schreiber, A.D.; Stahl, P.D.; Grinstein, S. Modulation of Rab5 and Rab7 recruitment to phagosomes by phosphatidylinositol 3-kinase. Mol Cell Biol, 2003, 23 (7), 2501-2514. (Pubitemid 36351030)
97. Parashuraman, S.; Madan, R.; Mukhopadhyay, A. NSF independent fusion of Salmonella-containing late phagosomes with early endosomes. FEBS Lett, 2010, 584 (6), 1251-1256.
98. Amano, A.; Nakagawa, I.; Yoshimori, T. Autophagy in innate immunity against intracellular bacteria. J Biochem, 2006, 140 (2), 161-166. (Pubitemid 44618901)
99. Smith-Garvin, J.E.; Koretzky, G.A.; Jordan, M.S. T cell activation. Annu Rev Immunol, 2009, 27 :591-619.
100. Uchiya, K.; Barbieri, M.A.; Funato, K.; Shah, A.H.; Stahl, P.D.; Groisman, E.A. A Salmonella virulence protein that inhibits cellular trafficking. Embo J, 1999, 18 (14), 3924-3933. (Pubitemid 29335845)
101. Brumell, J.H.; Rosenberger, C.M.; Gotto, G.T.; Marcus, S.L.; Finlay, B.B. SifA permits survival and replication of Salmonella typhimurium in murine macrophages. Cell Microbiol, 2001, 3 (2), 75-84. (Pubitemid 32156717)
102. Petrovska, L.; Aspinall, R.J.; Barber, L.; Clare, S.; Simmons, C.P.; Stratford, R.; Khan, S.A.; Lemoine, N.R.; Frankel, G.; Holden, D.W.; Dougan, G. Salmonella enterica serovar Typhimurium interaction with dendritic cells: impact of the sifA gene. Cell Microbiol, 2004, 6 (11), 1071-1084. (Pubitemid 39386684)
103. Tierrez, A.; Garcia-del Portillo, F. New concepts in Salmonella virulence: the importance of reducing the intracellular growth rate in the host. Cell Microbiol, 2005, 7 (7), 901-909. (Pubitemid 40903314)
104. Garcia-del Portillo, F.; Nunez-Hernandez, C.; Eisman, B.; Ramos-Vivas, J. Growth control in the Salmonella-containing vacuole. Curr Opin Microbiol, 2008, 11 (1), 46-52.
105. Hazenbos, W.L.; Heijnen, I.A.; Meyer, D.; Hofhuis, F.M.; Renardel de Lavalette, C.R.; Schmidt, R.E.; Capel, P.J.; van de Winkel, J.G.; Gessner, J.E.; van den Berg, T.K.; Verbeek, J.S. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol, 1998, 161 (6), 3026-3032. (Pubitemid 28425728)
106. Nimmerjahn, F.; Ravetch, J.V. Fcgamma receptors: old friends and new family members. Immunity, 2006, 24 (1), 19-28. (Pubitemid 43077197)
107. Baudino, L.; Nimmerjahn, F.; Azeredo da Silveira, S.; Martinez-Soria, E.; Saito, T.; Carroll, M.; Ravetch, J.V.; Verbeek, J.S.; Izui, S. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a-and IgG2b-induced autoimmune hemolytic anemia in mice. J Immunol, 2008, 180 (3), 1948-1953.
108. Ravetch, J.V.; Bolland, S. IgG Fc receptors. Annu Rev Immunol, 2001, 19, 275-290. (Pubitemid 32368037)
109. Iruretagoyena, M.I.; Riedel, C.A.; Leiva, E.D.; Gutierrez, M.A.; Jacobelli, S.H.; Kalergis, A.M. Activating and inhibitory Fcgamma receptors can differentially modulate T cell-mediated autoimmunity. Eur J Immunol, 2008, 38 (8), 2241-2250.
110. Kalergis, A.M.; Ravetch, J.V. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med, 2002, 195 (12), 1653-1659. (Pubitemid 34666079)
111. Weinshank, R.L.; Luster, A.D.; Ravetch, J.V. Function and regulation of a murine macrophage-specific IgG Fc receptor, Fc gamma R-alpha. J Exp Med, 1988, 167 (6), 1909-1925.
112. Nimmerjahn, F.; Ravetch, J.V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science, 2005, 310 (5753), 1510-1512. (Pubitemid 41746349)
113. Nimmerjahn, F.; Ravetch, J.V. FcgammaRs in Health and Disease. Curr Top Microbiol Immunol, 2010.
114. Ravetch, J.V. Fc receptors. Curr Opin Immunol, 1997, 9 (1), 121-125. (Pubitemid 27095907)
115. Carreno, L.J.; Riedel, C.A.; Kalergis, A.M. Induction of tolerogenic dendritic cells by NF-kappaB blockade and Fcgamma receptor modulation. Methods Mol Biol, 2011, 677 (339-353.
116. Gonzalez, P.A.; Prado, C.E.; Leiva, E.D.; Carreno, L.J.; Bueno, S.M.; Riedel, C.A.; Kalergis, A.M. Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci U S A, 2008, 105 (39), 14999-15004.
117. Carreno, L.J.; Pacheco, R.; Gutierrez, M.A.; Jacobelli, S.; Kalergis, A.M. Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fc gamma receptors and costimulatory molecules on dendritic cells. Immunology, 2009, 128 (3), 334-341.
118. Joller, N.; Weber, S.S.; Muller, A.J.; Sporri, R.; Selchow, P.; Sander, P.; Hilbi, H.; Oxenius, A. Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting. Proc Natl Acad Sci U S A, 2010, 107 (47), 20441-20446.
119. McSorley, S.J.; Jenkins, M.K. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. Infect Immun, 2000, 68 (6), 3344-3348. (Pubitemid 30340429)
120. Pasteur, L.; Chamberland; Roux Summary report of the experiments conducted at Pouilly-le-Fort, near Melun, on the anthrax vaccination, 1881. Yale J Biol Med, 2002, 75 (1), 59-62.
121. Jeremiah, K.; Praygod, G.; Faurholt-Jepsen, D.; Range, N.; Andersen, A.B.; Grewal, H.M.; Friis, H. BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine? Thorax, 2010, 65 (12), 1072-1076.
122. Cautivo, K.M.; Bueno, S.M.; Cortes, C.M.; Wozniak, A.; Riedel, C.A.; Kalergis, A.M. Efficient lung recruitment of respiratory syncytial virusspecific Th1 cells induced by recombinant bacillus Calmette-Guerin promotes virus clearance and protects from infection. J Immunol, 2010, 185 (12), 7633-7645.
123. Guzman, C.A.; Borsutzky, S.; Griot-Wenk, M.; Metcalfe, I.C.; Pearman, J.; Collioud, A.; Favre, D.; Dietrich, G. Vaccines against typhoid fever. Vaccine, 2006, 24 (18), 3804-3811.
124. Janis, C.; Grant, A.J.; McKinley, T.J.; Morgan, F.J.; John, V.F.; Houghton, J.; Kingsley, R.A.; Dougan, G.; Mastroeni, P. In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivoinducible promoter. Infect Immun, 2011, 79 (6), 2481-2488.
125. Micoli, F.; Rondini, S.; Pisoni, I.; Proietti, D.; Berti, F.; Costantino, P.; Rappuoli, R.; Szu, S.; Saul, A.; Martin, L.B. Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi. Vaccine, 2011, 29 (4), 712-720.
126. Yu, B.; Yang, M.; Wong, H.Y.; Watt, R.M.; Song, E.; Zheng, B.J.; Yuen, K.Y.; Huang, J.D. A method to generate recombinant Salmonella typhi Ty21a strains expressing multiple heterologous genes using an improved recombineering strategy. Appl Microbiol Biotechnol, 2011, 91 (1), 177-188.
127. Kopecko, D.J.; Sieber, H.; Ures, J.A.; Furer, A.; Schlup, J.; Knof, U.; Collioud, A.; Xu, D.; Colburn, K.; Dietrich, G. Genetic stability of vaccine strain Salmonella Typhi Ty21a over 25 years. Int J Med Microbiol, 2009, 299 (4), 233-246.
128. Cheminay, C.; Hensel, M. Rational design of Salmonella recombinant vaccines. Int J Med Microbiol, 2008, 298 (1-2), 87-98. (Pubitemid 350225674)
129. Tacket, C.O.; Hone, D.M.; Curtiss, R., 3rd; Kelly, S.M.; Losonsky, G.; Guers, L.; Harris, A.M.; Edelman, R.; Levine, M.M. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect Immun, 1992, 60 (2), 536-541.
130. Mian, M.F.; Pek, E.A.; Chenoweth, M.J.; Coombes, B.K.; Ashkar, A.A. Humanized mice for Salmonella typhi infection: new tools for an old problem. Virulence, 2011, 2 (3), 248-252.
131. Simon, R.; Tennant, S.M.; Galen, J.E.; Levine, M.M. Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: Revisiting the role of host innate susceptibility and routes of challenge. Vaccine, 2011.
132. Freeman, J.A.; Rappl, C.; Kuhle, V.; Hensel, M.; Miller, S.I. SpiC is required for translocation of Salmonella pathogenicity island 2 effectors and secretion of translocon proteins SseB and SseC. J Bacteriol, 2002, 184 (18), 4971-4980. (Pubitemid 34971021)
133. Hensel, M.; Shea, J.E.; Gleeson, C.; Jones, M.D.; Dalton, E.; Holden, D.W. Simultaneous identification of bacterial virulence genes by negative selection. Science, 1995, 269 (5222), 400-403.
134. Wisner, A.L.; Desin, T.S.; Koch, B.; Lam, P.K.; Berberov, E.M.; Mickael, C.S.; Potter, A.A.; Koster, W. Salmonella enterica subspecies enterica serovar Enteritidis Salmonella pathogenicity island 2 type III secretion system: role in intestinal colonization of chickens and systemic spread. Microbiology, 2010, 156 (Pt 9), 2770-2781.
135. Khan, S.A.; Stratford, R.; Wu, T.; McKelvie, N.; Bellaby, T.; Hindle, Z.; Sinha, K.A.; Eltze, S.; Mastroeni, P.; Pickard, D.; Dougan, G.; Chatfield, S.N.; Brennan, F.R. Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors. Vaccine, 2003, 21 (5-6), 538-548. (Pubitemid 36091941)
136. Kirkpatrick, B.D.; McKenzie, R.; O'Neill, J.P.; Larsson, C.J.; Bourgeois, A.L.; Shimko, J.; Bentley, M.; Makin, J.; Chatfield, S.; Hindle, Z.; Fidler, C.; Robinson, B.E.; Ventrone, C.H.; Bansal, N.; Carpenter, C.M.; Kutzko, D.; Hamlet, S.; LaPointe, C.; Taylor, D.N. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine, 2006, 24 (2), 116-123. (Pubitemid 41752998)
137. Araya, D.V.; Quiroz, T.S.; Tobar, H.E.; Lizana, R.J.; Quezada, C.P.; Santiviago, C.A.; Riedel, C.A.; Kalergis, A.M.; Bueno, S.M. Deletion of a prophage-like element causes attenuation of Salmonella enterica serovar Enteritidis and promotes protective immunity. Vaccine, 2010, 28 (33), 5458-5466.
138. Karasova, D.; Sebkova, A.; Vrbas, V.; Havlickova, H.; Sisak, F.; Rychlik, I. Comparative analysis of Salmonella enterica serovar Enteritidis mutants with a vaccine potential. Vaccine, 2009, 27 (38), 5265-5270.
139. Isoda, R.; Simanski, S.P.; Pathangey, L.; Stone, A.E.; Brown, T.A. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector. Vaccine, 2007, 25 (1), 117-126. (Pubitemid 44855249)
140. Galen, J.E.; Zhao, L.; Chinchilla, M.; Wang, J.Y.; Pasetti, M.F.; Green, J.; Levine, M.M. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. Infect Immun, 2004, 72 (12), 7096-7106. (Pubitemid 39552379)
141. Mollenkopf, H.J.; Groine-Triebkorn, D.; Andersen, P.; Hess, J.; Kaufmann, S.H. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine, 2001, 19 (28-29), 4028-4035. (Pubitemid 32566328)
142. Spreng, S.; Gentschev, I.; Goebel, W.; Weidinger, G.; ter Meulen, V.; Niewiesk, S. Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis. Microbes Infect, 2000, 2 (14), 1687-1692.
143. Bueno, S.M.; Gonzalez, P.A.; Kalergis, A.M. Use of genetically modified bacteria to modulate adaptive immunity. Curr Gene Ther, 2009, 9 (3), 171-184.
144. Russmann, H.; Shams, H.; Poblete, F.; Fu, Y.; Galan, J.E.; Donis, R.O. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science, 1998, 281 (5376), 565-568. (Pubitemid 28357372)
145. Konjufca, V.; Wanda, S.Y.; Jenkins, M.C.; Curtiss, R., 3rd A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect Immun, 2006, 74 (12), 6785-6796. (Pubitemid 44913153)
146. Fensterle, J.; Bergmann, B.; Yone, C.L.; Hotz, C.; Meyer, S.R.; Spreng, S.; Goebel, W.; Rapp, U.R.; Gentschev, I. Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B. Cancer Gene Ther, 2008, 15 (2), 85-93.
147. Lee, S.H.; Mizutani, N.; Mizutani, M.; Luo, Y.; Zhou, H.; Kaplan, C.; Kim, S.W.; Xiang, R.; Reisfeld, R.A. Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer. Cancer Immunol Immunother, 2006, 55 (12), 1565-1574. (Pubitemid 44327844)
148. Medina, E.; Guzman, C.A.; Staendner, L.H.; Colombo, M.P.; Paglia, P. Salmonella vaccine carrier strains: effective delivery system to trigger antitumor immunity by oral route. Eur J Immunol, 1999, 29 (2), 693-699. (Pubitemid 29078532)
149. Meng, J.Z.; Dong, Y.J.; Huang, H.; Li, S.; Zhong, Y.; Liu, S.L.; Wang, Y.D. Oral vaccination with attenuated Salmonella enterica strains encoding T-cell epitopes from tumor antigen NY-ESO-1 induces specific cytotoxic Tlymphocyte responses. Clin Vaccine Immunol, 2010, 17 (6), 889-894.
150. Kotton, C.N.; Hohmann, E.L. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun, 2004, 72 (10), 5535-5547. (Pubitemid 39303661)
151. Angelakopoulos, H.; Hohmann, E.L. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun, 2000, 68 (4), 2135-2141. (Pubitemid 30164846)